Exploring how patients use a connected Internet-Of-Things system (A4A+) with off-the-shelf CE-marked devices to support asthma self-management? A mixed method study (ID 281)
Asthma UK Centre for Applied Research, Usher Institute, The University of Edinburgh
Abstract
Aim: Traditionally, clinicians support patients to plan their self-management strategies during face-to-face consultations. In the COVID pandemic, patients have had to rely on remote consultations to help them to live with their conditions. The Internet-of-Things can support remote self-management for asthma.
Methods: A4A+ collected data from smart devices (smart-inhaler, smart-watch, smart peak flow meter). Data were collated on an app and could be shared with practices in the form of a pdf which could be attached to patients’ records in DOCMAN. We interviewed a maximum variation sample of patients recruited via social media and explored their usage on the system. Thematic analysis used the BJ Fogg behavioural model. Descriptive analysis of their usage data stored in our database and Google Firebase enabled triangulation of findings.
Results: We interviewed 10 asthma patients (range of age/gender/asthma experience/action plan ownership/Apple/Android user/technological competences) before and after using A4A+ for one month during December 2020-Feburaury 2021. We interviewed one patient’s asthma nurse and three GPs on acceptability of the system and their views on the report format. Patients felt ‘positive’, found it ‘easy’ to use the system and chose to use devices they thought were “accurate”. 9533 self-management data-points (asthma symptoms, PEFR, inhaler usage, exercise intensity, heart rate, sleeping pattern, body/air temperature) were collected. Monitoring adjustments to medication, having asthma (or COVID) symptoms triggered and motivated them to adopt the system. Most patients chose to monitor their reliever inhaler rather than the preventer. Clinicians want to have an overall asthma score/status and reliever usage on the report.
Conclusion: Accelerated by COVID, a connected IoT system such as A4A+ could enable digital approaches to care by providing on-going self-management data to support remote consultation. However, building trust in devices and providing timely technology support for patients are needed to maintain patients’ motivation to use the system.
Funding: This project is funded by the MRC Confidence in Concept (ref: MRC/CiC7/71)
Conflicts of interest: CyH has received grant funding from the MRC CiC (ref: MRC/CiC7/71) to plan and carry out the study works. BM and HP have received grant funding from Philips NV. MB is Managing Director of Tactuum Ltd. OF contributes in a lay capacity to Teva Pharmaceuticals, AstraZeneca and WEGOHealth. Medical International Research and Smart Respiratory Products Ltd provided free smart peak flow devices for this research. Findair and Polar Electro (UK) have provided their apps and API connections to the A4A+ system.
The conference has been instigated and organised by PCRS. We are grateful to sponsors and exhibitors who have contributed funding towards this event in return for exhibition space. Neither sponsors or exhibitors have had any input into the agenda or the selection of speakers with the exception of any sponsored satellite symposia which are clearly indicated. View the full list of sponsors.